Bifogade filer
PDF
Kurs & Likviditet
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Large Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
"Continued growth"
1 JULY - 30 SEPTEMBER 2019 (3 MONTHS)
- Net sales increased by 39 percent to SEK 802 million (578), of which organic growth amounted to 4 percent and acquired growth amounted to 34 percent.
- EBITA increased by 27 percent to SEK 65 million (51), corresponding to an EBITA-margin of 8.1 percent (8.8).
- Profit after tax increased by 11 percent to SEK 27 million (24).
- Cash flow from operating activities amounted to SEK 61 million (17), including IFRS 16 effect of SEK 23 million (0).
- Net sales increased by 39 percent to SEK 2,491 million (1,797), of which organic growth amounted to 3 percent and acquired growth amounted to 34 percent.
- EBITA increased by 18 percent to SEK 203 million (171), corresponding to an EBITA-margin of 8.1 percent (9.5).
- Profit after tax increased by 9 percent and amounted to SEK 93 million (85).
- Earnings per share amounted to SEK 3.36 (3.53). For the 12-month period, earnings per share amounted to SEK 5.12 (5.21).
- Cash flow from operating activities amounted to SEK 225 million (85), including IFRS 16 effect of SEK 65 million (0).
- During the interim period, the company raised SEK 501 million in a rights issue.
- The equity ratio amounted to 45 percent (40).
- Return on working capital (P/WC) amounted to 51 percent (66).
- During the period three acquisitions have been completed, with a combined annual sale of about SEK 225 million.
AddLife AB (publ)
For more information, contact;
Kristina Willgård, CEO, kristina.willgard@add.life,+46 70 510 12 23
Martin Almgren, CFO, martin.almgren@add.life,+46 70 228 15 45
www.add.life
Teleconference
Investors, analysts and the media are invited to a teleconference at which CEO Kristina Willgård and CFO Martin Almgren will present the interim report. The presentation will be given in English and take about 20 minutes. after which there will be an opportunity to ask questions.
The teleconference will be at 10:00 a.m. on 7 November 2019
The presentation will be available via the following link: https://5569958126.globalmeet.com/MartinAlmgren2
Please call on: +46 8 22 90 90 code: 327497
AddLife is an independent player in the Life Science industry that offers high-quality products, services and advice to both the private and public sectors, mainly in the Nordic region and rest of Europe. AddLife has more than 900 employees in some 40 operating subsidiaries. The Group currently has net sales of around SEK 3.2 billion. AddLife shares are listed on Nasdaq Stockholm.
This information is information that AddLife AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 7 November 2019 at 08:00 a.m. CET.